Helicobacter

(Redirected from Helicobacteraceae)
Jump to: navigation, search
Helicobacter
Scanning electron micrograph of Helicobacter bacteria.
Scanning electron micrograph of Helicobacter bacteria.
Scientific classification
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Epsilon Proteobacteria
Order: Campylobacterales
Family: Helicobacteraceae
Genus: Helicobacter
Goodwin et al. 1989
Species

H. acinonychis
H. anseris
H. aurati
H. bilis
H. bizzozeronii
H. brantae
H. canadensis
H. canis
H. cholecystus
H. cinaedi
H. cynogastricus
H. felis
H. fennelliae
H. ganmani
H. hepaticus
H. mesocricetorum
H. marmotae
H. muridarum
H. mustelae
H. pametensis
H. pullorum
H. pylori
H. rappini
H. rodentium
H. salomonis
H. trogontum
H. typhlonius
H. winghamensis

WikiDoc Resources for Helicobacter

Articles

Most recent articles on Helicobacter

Most cited articles on Helicobacter

Review articles on Helicobacter

Articles on Helicobacter in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Helicobacter

Images of Helicobacter

Photos of Helicobacter

Podcasts & MP3s on Helicobacter

Videos on Helicobacter

Evidence Based Medicine

Cochrane Collaboration on Helicobacter

Bandolier on Helicobacter

TRIP on Helicobacter

Clinical Trials

Ongoing Trials on Helicobacter at Clinical Trials.gov

Trial results on Helicobacter

Clinical Trials on Helicobacter at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Helicobacter

NICE Guidance on Helicobacter

NHS PRODIGY Guidance

FDA on Helicobacter

CDC on Helicobacter

Books

Books on Helicobacter

News

Helicobacter in the news

Be alerted to news on Helicobacter

News trends on Helicobacter

Commentary

Blogs on Helicobacter

Definitions

Definitions of Helicobacter

Patient Resources / Community

Patient resources on Helicobacter

Discussion groups on Helicobacter

Patient Handouts on Helicobacter

Directions to Hospitals Treating Helicobacter

Risk calculators and risk factors for Helicobacter

Healthcare Provider Resources

Symptoms of Helicobacter

Causes & Risk Factors for Helicobacter

Diagnostic studies for Helicobacter

Treatment of Helicobacter

Continuing Medical Education (CME)

CME Programs on Helicobacter

International

Helicobacter en Espanol

Helicobacter en Francais

Business

Helicobacter in the Marketplace

Patents on Helicobacter

Experimental / Informatics

List of terms related to Helicobacter


Overview

Helicobacter is a genus of Gram-negative bacteria possessing a characteristic helix shape. They were initially considered to be members of the Campylobacter genus, but since 1989 they have been grouped in their own genus.[1][2][3]

Some species have been found living in the lining of the upper gastrointestinal tract, as well as the liver of mammals and some birds.[4]. The most widely known species of the genus is H. pylori which infects up to 50% of the human population.[3] Some strains of this bacterium are pathogenic to humans as it is strongly associated with peptic ulcers, chronic gastritis, duodenitis, and stomach cancer. It also serves as the type species of the genus.

Helicobacter spp. are able to thrive in the very acidic mammalian stomach by producing large quantities of the enzyme urease, which locally raises the pH from ~2 to a more biocompatible range of 6 to 7.[5] Bacteria belonging to this genus are usually susceptible to antibiotics such as penicillin, are microaerophilic (require small amounts of oxygen), and are fast-moving with their flagella.[6][7]

Helicobacter Facts.[8]

Curved cells discovered in 1979 in stomach biopsied specimens.

Causes 90% of stomach & duodenal ulcers.

People with type O blood have a 1.5-2X higher rate of ulcers.

Produces large amounts of urease.

Infection common especially in lower socioeconomic class/developing nations.

Humans primary reservoir.

Person-to-person spread via fecal-oral route.

Ubiquitous, no seasonal incidence.

Diseases

In 1994, the World Health Organization’s International Agency for Research on Cancer (IARC) classified H. pylori as a Group 1 carcinogen. This decision was based on the results of numerous studies that confirmed the association between H. pylori infection and gastric adenocarcinoma. H. pylori infection also significantly increases the risk of gastric lymphoma of mucosa-associated lymphoid tissue (MALT) (Suerbaum, 2002).

While H. pylori remains the most medically important bacterial inhabitant of the human stomach, other species of the genus Helicobacter have been identified in other mammals and some birds, and some of these can infect humans.[9] Helicobacter species have also been found to infect the livers of certain mammals and to cause liver disease.[10]

Diagnosis

H. pylori infection can be confirmed by invasive or noninvasive methods. Invasive tests require upper esophagogastroduodenal (EGD) endoscopy, which is considered the reference method of diagnosis. During endoscopy, biopsy specimens of the stomach and duodenum are obtained, and the diagnosis of H. pylori can be made by urease testing, histology and/or culture. If possible, noninvasive testing is done before tissue testing.

H. pylori stool antigen (HpSA) testing is based on monoclonal antibody immunochromatography of stool samples. This testing method identifies active infection and can be used to detect eradication after treatment. A sensitivity and specificity range of 92–98% is reported in the literature for stool antigen testing.

Serological assays (blood serum) measure specific H. pylori immunoglobulin G (IgG) antibodies that can determine if an individual has been infected. The sensitivity and specificity of these assays range from 80–95%, depending on the assay used. Serological testing has been the mainstay of H. pylori diagnosis, particularly in primary care, due to the accessibility, rapid results and low cost of this testing method.

Urease test, Urease Breath Test (UBT) (positive in as little as 2 hours) [11]

Treatment

Therapy with tetracycline, metronidazole, bismuth (Peptobismol)

References

  1. Goodwin CS, Armstrong JA, Chilvers T; et al. (1989). "Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively". Int. J. Syst. Bacteriol. 39: 397&ndash, 405.
  2. Vandamme P, Falsen E, Rossaq R; et al. (1991). "Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov". Int. J. Syst. Bacteriol. 41: 88&ndash, 103.
  3. 3.0 3.1 Yamaoka Y (editor). (2008). Helicobacter pylori: Molecular Genetics and Cellular Biology. Caister Academic Press. ISBN 978-1-904455-31-8 .
  4. Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. ISBN 0-8385-8529-9.
  5. Dunn BE, Cohen H, Blaser MJ (1997). "Helicobacter pylori". Clin Microbiol Rev. 10: 720&ndash, 741.
  6. Hua JS, Zheng PY, Ho B (1999). "Species differentiation and identification in the genus of Helicobacter" (PDF). World Journal of Gastroenterology. 5 (1): 7&ndash, 9.
  7. Rust; et al. (2008). "Helicobacter Flagella, Motility and Chemotaxis". Helicobacter pylori: Molecular Genetics and Cellular Biology (Yamaoka Y, ed.). Caister Academic Press. ISBN 978-1-904455-31-8 .
  8. Kathleen Park Talaro (2006). Foundations in Microbiology (6th ed. ed.). McGraw Hill. ISBN 0072994959.
  9. Stuart L. Hazell; Mobley, Harry L. T.; George L. Mendz (2001). Helicobacter pylori: Physiology and Genetics. American Society Microbiology. ISBN 1-55581-213-9.
  10. Starzyñska T, Malfertheiner P (2006). "Helicobacter and digestive malignancies". Helicobacter. 11 Suppl 1: 32–5. doi:10.1111/j.1478-405X.2006.00431.x. PMID 16925609. Unknown parameter |month= ignored (help)
  11. Robert P H Logan, Marjorie M Walker (2001). "Epidemiology and diagnosis of Helicobacter pylori infection ". BMJ 2001;323:920-922 ( 20 October ). 323: &ndash, 741. doi:10.1136/bmj.323.7318.920. PMID 11668141.

See also

External links



Linked-in.jpg